Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
ACS Appl Mater Interfaces. 2020 Oct 14;12(41):45830-45837. doi: 10.1021/acsami.0c13995. Epub 2020 Sep 30.
Herein, we report a novel strategy to enhance the antisense activity and the pharmacokinetics of therapeutic oligonucleotides. Through the DNA hybridization chain reaction, DNA hairpins modified with poly(ethylene glycol) (PEG) form a bottlebrush architecture consisting of a double-stranded DNA backbone, PEG side chains, and antisense overhangs. The assembled structure exhibits high PEG density on the surface, which suppresses unwanted interactions between the DNA and proteins (e.g., enzymatic degradation) while allowing the antisense overhangs to hybridize with the mRNA target and thereby deplete target protein expression. We show that these PEGylated bottlebrushes targeting oncogenic KRAS can achieve much higher antisense efficacy compared with unassembled hairpins with or without PEGylation and can inhibit the proliferation of lung cancer cells bearing the G12C mutant KRAS gene. Meanwhile, these structures exhibit elevated blood retention times in vivo due to the biological stealth properties of PEG and the high molecular weight of the overall assembly. Collectively, this self-assembly approach bears the characteristics of a simple, safe, yet highly translatable strategy to improve the biopharmaceutical properties of therapeutic oligonucleotides.
在这里,我们报告了一种增强治疗性寡核苷酸反义活性和药代动力学的新策略。通过 DNA 杂交链式反应,用聚乙二醇(PEG)修饰的 DNA 发夹形成一种由双链 DNA 骨架、PEG 侧链和反义突出组成的刷状结构。组装后的结构在表面具有高 PEG 密度,抑制了 DNA 与蛋白质(如酶降解)之间的不必要相互作用,同时允许反义突出与 mRNA 靶标杂交,从而耗尽靶蛋白表达。我们表明,这些针对致癌 KRAS 的 PEG 化刷状结构与未经组装的带有或不带有 PEG 化的发夹相比,具有更高的反义功效,并能抑制携带 G12C 突变 KRAS 基因的肺癌细胞的增殖。同时,由于 PEG 的生物隐身特性和整体组装的高分子量,这些结构在体内表现出更高的血液保留时间。总的来说,这种自组装方法具有简单、安全但高度可转化的特点,可以改善治疗性寡核苷酸的生物制药特性。